NCT02430610View on ClinicalTrials.gov

Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

February 1, 2021

Conditions
Uterine Cervical Neoplasms
Interventions
PROCEDURE

Irreversible electroporation (IRE)

Irreversible Electroportion For Unresectable Uterine Cervical Neoplasms guide with ultrasound or/and CT.

DEVICE

NanoKnife

Trial Locations (1)

Unknown

Biological treatment center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02430610 - Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms | Biotech Hunter | Biotech Hunter